August 2025 in “International Journal of Nanomedicine” Metal-organic frameworks can help heal wounds, reduce scars, and promote hair growth, but more research is needed.
July 2025 in “International Journal of Trichology” Hair shedding increases at the end of summer due to seasonal changes.
1 citations
,
July 2025 in “The Open Dermatology Journal” Tissue engineering in cosmetics offers safer, more effective products and ethical alternatives to animal testing.
January 2026 in “JPRAS Open” PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.
February 2024 in “Journal of Cosmetic Dermatology” White hair patch repigmented and hair regrew in a balding patient after treatment with exosomes and laser.
Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.
10 citations
,
July 2018 in “Our Dermatology Online” Some vitamins and minerals are important for preventing hair loss, but treating hair loss with them without a known deficiency is not proven effective.
1 citations
,
August 2025 in “Medicina” Non-invasive imaging techniques improve scalp condition diagnosis and patient quality of life.
1 citations
,
December 2020 in “Harran Üniversitesi týp fakültesi dergisi” Many people with hair loss had low iron and ferritin levels.
December 2025 in “Dietetics” European olive products are beneficial for skin care and are expected to become more important.
July 2025 in “Biomolecules” Adenosine may help with hair loss, but more research is needed.
July 2025 in “JOJ Dermatology & Cosmetics” Both treatments improved hair quality and thickness equally, with mild side effects.
July 2025 in “International Journal of Trichology” Ethical standards are crucial in cosmetic medicine to maintain integrity.
April 2025 in “Journal of the International Society of Sports Nutrition” Creatine does not cause hair loss.
March 2025 in “Journal of Cutaneous and Aesthetic Surgery” Non-laser devices show promise in treating hair issues, but more research is needed.
February 2025 in “Healthcare” Caffeine may help with hair loss, but more research is needed.
November 2024 in “Applied Sciences” Placenta products might help with hair loss, but more research is needed.
March 2024 in “Journal of clinical medicine” Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.
November 2023 in “Cosmetics” Rice derivatives in conditioners protect and improve hair health.
January 2023 in “Journal of surgery and research” New treatment effectively reverses hair thinning in most patients with mild side effects.
January 2023 in “Dermatologic Therapy” The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.
July 2024 in “International Journal of Molecular Sciences” RF-based therapies might help treat hair loss.
March 2023 in “Medico Research Chronicles” Omega-3 fatty acids may help manage hair loss in middle-aged women.
39 citations
,
August 2021 in “JAAD International” COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.
13 citations
,
January 2014 in “PubMed” Adiantum capillus-veneris Linn reduced hair loss and improved hair growth in mice with testosterone-induced alopecia.
5 citations
,
June 2025 in “Journal of Functional Biomaterials” 3D bioprinting offers new ways to treat head and neck defects with bioinks that mimic natural tissues.
March 2026 in “Pharmaceutics” TheDES improve drug delivery through the skin but need more safety checks.
November 2025 in “Cosmetics” Rice germ oil improves hair health, but adding ferulic acid offers limited benefits and may worsen chemically damaged hair.
The combination therapy improved hair growth and thickness in people with androgenetic alopecia.
July 2025 in “American Journal of Clinical Dermatology” Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.